A key element to restore the liveliness and the aging process of immune system is said to be identified by UCSF researcher, published by Journal Clinical Immunology.
A low dose of the drug lenalidomide can stimulate the body's immune-cell protein , which decrease production during aging, and rebalance the levels of several key cytokines, is identified by the team which researched on the cell of the blood.
The identification of a drug to reverse the immunological decline in aging, known as immunosenescence, found out by Edward J. Goetzl, MD, at UCSF and the National Institute on Aging.
The researchers also found that lenalidomide had many other beneficial effects on the aged T cells, plans to begin larger-scale clinical trials of the drug effectiveness in 2011.
Via: [Studying Health.blog]